Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra B Gabelli

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Biomolecules|March 1, 2019
Structural Determinants of Isoform Selectivity in PI3K InhibitorsMichelle S Miller, Philip E Thompson, Sandra B Gabelli
Advances in Biological Regulation|December 19, 2021
Elusive structure of mammalian DGKsQianqian Ma, Lakshmi Srinivasan, Sandra B Gabelli, et al.
The FEBS Journal|July 1, 2015
Oncogenic mutations weaken the interactions that stabilize the p110α-p85α heterodimer in phosphatidylinositol 3-kinase αIgnacia Echeverria, Yunlong Liu, Sandra B Gabelli, et al.
Proteins|October 31, 2009
Binding of nitrogen-containing bisphosphonates (N-BPs) to the Trypanosoma cruzi farnesyl diphosphate synthase homodimerChuan-Hsiang Huang, Sandra B Gabelli, Eric Oldfield, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2023
Structure of WNT inhibitor adenomatosis polyposis coli down-regulated 1 (APCDD1), a cell-surface lipid-binding proteinFu-Lien Hsieh, Tao-Hsin Chang, Sandra B Gabelli, et al.
Cell Cycle (Georgetown, Tex.)|April 18, 2008
Insights into the oncogenic effects of PIK3CA mutations from the structure of p110alpha/p85alphaChuan-Hsiang Huang, Diana Mandelker, Sandra B Gabelli, et al.
Channels (Austin, Tex.)|July 29, 2015
Calmodulin and Ca(2+) control of voltage gated Na(+) channelsSandra B Gabelli, Jesse B Yoder, Gordon F Tomaselli, et al.
Biochemistry|April 28, 2010
Mutation of Asn28 disrupts the dimerization and enzymatic activity of SARS 3CL(pro) Jennifer Barrila, Sandra B Gabelli, Usman Bacha, et al.
Biochimica Et Biophysica Acta|December 8, 2009
Somatic mutations in PI3Kalpha: structural basis for enzyme activation and drug designSandra B Gabelli, Diana Mandelker, Oleg Schmidt-Kittler, et al.
Advances in Enzyme Regulation|November 2, 2010
Capitalizing on tumor genotyping: towards the design of mutation specific inhibitors of phosphoinsitide-3-kinaseSandra B Gabelli, Krisna C Duong-Ly, Evan T Brower, et al.
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Biomolecules|March 1, 2019
Structural Determinants of Isoform Selectivity in PI3K InhibitorsMichelle S Miller, Philip E Thompson, Sandra B Gabelli
Advances in Biological Regulation|December 19, 2021
Elusive structure of mammalian DGKsQianqian Ma, Lakshmi Srinivasan, Sandra B Gabelli, et al.
The FEBS Journal|July 1, 2015
Oncogenic mutations weaken the interactions that stabilize the p110α-p85α heterodimer in phosphatidylinositol 3-kinase αIgnacia Echeverria, Yunlong Liu, Sandra B Gabelli, et al.
Proteins|October 31, 2009
Binding of nitrogen-containing bisphosphonates (N-BPs) to the Trypanosoma cruzi farnesyl diphosphate synthase homodimerChuan-Hsiang Huang, Sandra B Gabelli, Eric Oldfield, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2023
Structure of WNT inhibitor adenomatosis polyposis coli down-regulated 1 (APCDD1), a cell-surface lipid-binding proteinFu-Lien Hsieh, Tao-Hsin Chang, Sandra B Gabelli, et al.
Cell Cycle (Georgetown, Tex.)|April 18, 2008
Insights into the oncogenic effects of PIK3CA mutations from the structure of p110alpha/p85alphaChuan-Hsiang Huang, Diana Mandelker, Sandra B Gabelli, et al.
Channels (Austin, Tex.)|July 29, 2015
Calmodulin and Ca(2+) control of voltage gated Na(+) channelsSandra B Gabelli, Jesse B Yoder, Gordon F Tomaselli, et al.
Biochemistry|April 28, 2010
Mutation of Asn28 disrupts the dimerization and enzymatic activity of SARS 3CL(pro) Jennifer Barrila, Sandra B Gabelli, Usman Bacha, et al.
Biochimica Et Biophysica Acta|December 8, 2009
Somatic mutations in PI3Kalpha: structural basis for enzyme activation and drug designSandra B Gabelli, Diana Mandelker, Oleg Schmidt-Kittler, et al.
Advances in Enzyme Regulation|November 2, 2010
Capitalizing on tumor genotyping: towards the design of mutation specific inhibitors of phosphoinsitide-3-kinaseSandra B Gabelli, Krisna C Duong-Ly, Evan T Brower, et al.
Pageof 11